2024 年 11 月 8 日 《关于深圳中科飞测科技股份有限公司股票交易异常波动 的询证函》的回函 致：深圳中科飞测科技股份有限公司 贵公司《关于深圳中科飞测科技股份有限公司股票交易异常波动的询证函》 已收悉，现就公司询证事项回复如下： 1、截至目前，作为贵公司控股股东，不存在正在筹划并购重组、股份发行、 债务重组、业务重组、资产剥离和资产注入等重大事项，亦不存在其他应披露 而未披露的重大信息。 2、本公司在贵公司本次股票异常波动期间，不存在买卖贵公司股票的情况。 （本页以下无正文） （本页无正文，为控股股东《<关于深圳中科飞测科技股份有限公司股票交 易异常波动的询证函>的回函》之签署页） 控股股东：苏州翌流明光电科技有限公司 《关于深圳中科飞测科技股份有限公司股票交易异常波动 的询证函》的回函 《关于深圳中科飞测科技股份有限公司股票交易异常波动 的询证函》的回函 致：深圳中科飞测科技股份有限公司 贵公司《关于深圳中科飞测科技股份有限公司股票交易异常波动的询证函》 已收悉，现就公司询证事项回复如下： 1、截至目前，作为贵公司实际控制人，不存在正在筹划并购重组、股份发 行、债务重组、业务重组、资产剥离和资产注 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company with a target price of 91.0 CNY, compared to the current price of 67.72 CNY [1]. Core Insights - The company achieved a record high revenue of 3.49 billion CNY in Q3 2024, reflecting a year-on-year increase of 56.79% and a quarter-on-quarter increase of 52.70%. The gross margin improved to 49.64%, up 2.06 percentage points year-on-year and 11.77 percentage points quarter-on-quarter [1]. - The company is experiencing high growth in revenue and orders, supported by an optimized product structure and increased domestic demand for semiconductor detection equipment. The backlog of contracts increased to 6.98 billion CNY, providing a solid foundation for future growth [1]. - The semiconductor equipment market is expected to continue its high growth trajectory due to industry recovery and innovations in end-user applications such as AI and electric vehicles. Domestic manufacturers are likely to gain market share due to advantages in customization and supply stability [1]. - The company has maintained high levels of R&D investment, successfully developing nine series of equipment and three series of software products, with significant application in leading domestic clients [1]. Financial Summary - For the first three quarters of 2024, the company reported total revenue of 812 million CNY, a year-on-year increase of 38.21%. The gross margin was 47.69%, down 2.17 percentage points year-on-year. The net profit attributable to the parent company was -52 million CNY [2]. - The projected revenues for 2024-2026 have been revised upwards to 1.32 billion CNY, 1.96 billion CNY, and 2.61 billion CNY, respectively. The net profit forecast for 2024 has been adjusted to 39 million CNY, with projections of 283 million CNY and 492 million CNY for 2025 and 2026, respectively [2][5].

Investment Rating - The report maintains a "Buy" rating for Zhongke Feice (688361 SH) [3] Core Views - Zhongke Feice reported strong Q3 2024 revenue growth of 56 79% YoY to 349 million RMB, but net profit attributable to shareholders declined by 51 39% YoY to 16 million RMB [3] - Gross margin improved to 49 64% in Q3 2024, up 2 06 percentage points YoY, driven by accounting policy changes and product mix optimization [3] - The company has a robust order backlog with contract liabilities and inventory reaching 698 million RMB and 1 555 billion RMB respectively at the end of Q3 2024 [3] - Zhongke Feice is benefiting from domestic substitution trends in the semiconductor industry, with its product portfolio covering both bright-field and dark-field nanoscale wafer defect inspection equipment [4][5] - The company is expected to achieve net profits of 103 million RMB, 257 million RMB, and 429 million RMB in 2024, 2025, and 2026 respectively, with corresponding P E ratios of 210x, 84x, and 51x [5] Financial Performance - For the first three quarters of 2024, Zhongke Feice reported revenue of 812 million RMB, a 38 21% YoY increase, but net profit attributable to shareholders was -52 million RMB, down 165 85% YoY [3] - The company's gross margin for the first three quarters of 2024 was 47 69%, down 2 17 percentage points YoY [3] - Operating cash flow for 2024 is projected to be 780 million RMB, a significant improvement from -52 million RMB in 2023 [9] - The company's EPS is forecasted to grow from 0 32 RMB in 2024 to 1 34 RMB in 2026 [9] Product Development - Zhongke Feice has successfully shipped both bright-field and dark-field nanoscale wafer defect inspection equipment to leading domestic logic and memory customers [4] - The company's OCD equipment has shown promising results in client validation, meeting performance requirements [4] - Zhongke Feice continues to advance its product lines, including patternless wafer defect inspection, patterned wafer defect inspection, film thickness measurement, and overlay accuracy measurement equipment [4] Market Position - Zhongke Feice is positioned as a leading domestic player in semiconductor metrology and inspection equipment [5] - The company is well-positioned to capture larger market share in the domestic semiconductor equipment industry [4] - With increasing R&D investment, Zhongke Feice has accelerated its new product development cycle, particularly in advanced models [5]

Investment Rating - The report maintains a "Buy" rating for the company [5]. Core Views - The company's performance in Q3 met expectations, with accelerated deliveries and steady progress in new product development. The company is focusing on high R&D investments to support its product lineup, particularly in the electron beam critical dimension measurement equipment, which will enhance its capabilities in the electron beam sector [2][3]. Financial Summary - Revenue for Q1-Q3 2024 reached 0.812 billion, representing a year-on-year increase of 38.21%. The net profit attributable to the parent company was -0.052 billion, while the net profit excluding non-recurring items was -0.125 billion. The poor profit performance is attributed to increased R&D investments aimed at positioning for new products [3][4]. - For Q3 2024, revenue was 0.349 billion, up 56.79% year-on-year, with a net profit of 0.016 billion. The gross margin for Q3 was 49.64%, an increase of 2.06 percentage points year-on-year and 11.77 percentage points quarter-on-quarter [3][4]. - The company has adjusted its revenue forecasts for 2024-2026 to 1.350 billion, 2.012 billion, and 3.004 billion respectively, up from previous estimates of 1.301 billion, 1.934 billion, and 2.845 billion. EPS estimates for the same period have been revised down to 0.31, 0.83, and 2.05 yuan respectively [3][4]. Product Development - The company is advancing its product lineup, including: 1. Mass-produced products such as non-graphic wafer defect detection, which is gaining market share. 2. Ongoing development in advanced packaging fields like HBM and 2.5/3D. 3. Steady progress in the development of advanced models for film thickness measurement and overlay accuracy measurement [3]. - The company is also validating products with domestic customers, with small batch shipments for bright field and dark field products [3]. Market Positioning - The company is positioned to cover both optical and electron beam measurement sectors, which opens up significant growth potential. The electron beam critical dimension measurement equipment accounts for 8.1% of the value of measurement equipment, indicating a strategic move to enhance its product offerings [3]. Valuation - The target price has been raised to 94.32 yuan from the previous 81.31 yuan, based on a 15x PS for 2025, reflecting the company's growth potential and low domestic replacement rate in the measurement segment [3][5].

Investment Rating - The report maintains a "Buy" rating for the company, reflecting a positive outlook on its future performance [6] Core Views - The company's gross margin has significantly rebounded, with a single-quarter revenue growth rate of nearly 60% [2] - New orders continue to grow, and the verification of new equipment is progressing smoothly, indicating potential for future expansion [5] - The company's R&D investment remains high, with a slight decline in R&D expense ratio, supporting long-term growth [5] - The domestic market for inspection and measurement equipment has significant potential for localization, with urgent demand for self-sufficiency [6] Financial Performance - In Q3 2024, the company reported revenue of 349 million yuan, a year-on-year increase of 56.8%, and a quarter-on-quarter increase of 52.7% [4] - The gross margin in Q3 2024 was 49.6%, an increase of 11.7 percentage points compared to Q2 2024, leading to a positive net profit of 16.13 million yuan [5] - For the first nine months of 2024, the company's revenue was 812 million yuan, a year-on-year increase of 38.2%, with a gross margin of 47.69% [4] - The company's R&D expenses for the first nine months of 2024 reached 335 million yuan, a year-on-year increase of 131.8%, with an R&D expense ratio of 41.2% [5] Market and Industry Analysis - The domestic inspection and measurement equipment industry has significant potential for localization, with urgent demand for self-sufficiency due to the importance of these devices in the semiconductor supply chain [6] - The company is expected to maintain a rapid increase in market share and expand its product portfolio through continuous technological breakthroughs [6] Financial Projections - The report forecasts the company's net profit for 2024-2026 to be 143 million yuan, 210 million yuan, and 332 million yuan, respectively, with year-on-year growth rates of 1.9%, 46.6%, and 58.5% [6] - The company's revenue is expected to grow to 1.37 billion yuan in 2024, 1.86 billion yuan in 2025, and 2.37 billion yuan in 2026, with year-on-year growth rates of 53.7%, 35.7%, and 27.3%, respectively [7] - The gross margin is projected to be 46.4% in 2024, 47.2% in 2025, and 48.1% in 2026 [7]

Investment Rating - The report maintains a rating of "Accumulate" for the company [1] Core Views - Q3 revenue shows significant growth, with a quarter-on-quarter recovery in profits. The company achieved a revenue of 812 million yuan in the first three quarters of 2024, representing a year-on-year increase of 38.21%. In Q3 alone, revenue reached 349 million yuan, up 56.79% year-on-year and 52.70% quarter-on-quarter. However, the net profit attributable to the parent company was -52 million yuan, indicating a shift from profit to loss year-on-year [2] - The gross margin improved both year-on-year and quarter-on-quarter, with Q3 gross margin at 49.64%, up 2.06 percentage points year-on-year and 11.78 percentage points quarter-on-quarter. R&D expenses remained high, reaching 128 million yuan in Q3, a year-on-year increase of 167% [3] - Inventory and contract liabilities continued to grow year-on-year, indicating a robust order backlog. As of the end of Q3 2024, inventory stood at 1.555 billion yuan, up 46% year-on-year, while contract liabilities were 698 million yuan, up 33% year-on-year [3] - The company is expanding its product lines and making progress in advanced process R&D, with various equipment types covering 2Xnm and above process nodes. The company has a strong market share in the domestic advanced packaging sector and is seeing steady growth in orders for its measurement equipment [4] Financial Forecasts and Valuation - The company is expected to significantly increase its R&D investment in 2024, with projected net profits attributable to the parent company of 440 million yuan in 2024, 2.64 billion yuan in 2025, and 4.19 billion yuan in 2026. The current market capitalization corresponds to dynamic P/E ratios of 498, 83, and 52 times for the respective years [5]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - Q3 revenue shows significant growth, with a quarter-on-quarter recovery in profits. The company achieved a revenue of 812 million yuan in the first three quarters of 2024, representing a year-on-year increase of 38.21%. The net profit attributable to the parent company was -52 million yuan, with a non-recurring net profit of -125 million yuan, indicating a shift from profit to loss year-on-year. In Q3 alone, revenue reached 349 million yuan, up 56.79% year-on-year and 52.70% quarter-on-quarter. The net profit attributable to the parent company was 16 million yuan, down 51.39% year-on-year, while the non-recurring net profit was -10 million yuan, indicating a loss year-on-year [2][3]. Financial Performance - Q3 gross margin improved both year-on-year and quarter-on-quarter, with a gross margin of 49.64% in Q3, up 2.06 percentage points year-on-year and 11.78 percentage points quarter-on-quarter. The net profit margin for Q3 was 4.63%, down 10.30 percentage points year-on-year but up 49.42 percentage points quarter-on-quarter. The decline in net profit margin year-on-year is primarily due to high R&D expenditures for new product iterations and upgrades [3]. - Inventory and contract liabilities continue to grow year-on-year, indicating a robust order backlog. As of the end of Q3 2024, inventory stood at 1.555 billion yuan, up 46% year-on-year, and contract liabilities were 698 million yuan, up 33% year-on-year [3]. Product Development - The company is expanding its product lines and making progress in advanced process R&D. Key developments include: 1. Non-graphical wafer inspection equipment covering 2Xnm and above process nodes, with 1Xnm equipment under development. 2. Graphical defect detection equipment widely used in logic, storage, and advanced packaging fields, with significant market share among leading domestic clients. 3. 3D morphology measurement equipment supporting 2Xnm and above processes, with steady order growth. 4. Thin film thickness measurement equipment covering major integrated circuit clients, with continuous order growth and increasing market share. 5. Critical dimension measurement equipment with successful batch sales for 90nm and above process nodes, and 2Xnm equipment validated by leading domestic clients [4]. Earnings Forecast and Valuation - The report projects the company's net profit attributable to the parent company for 2024-2026 to be 440 million yuan, 2.64 billion yuan, and 4.19 billion yuan respectively. The current market capitalization corresponds to dynamic P/E ratios of 498, 83, and 52 times for the respective years. Given the company's high growth potential in the semiconductor measurement equipment sector, the "Accumulate" rating is maintained [5].

Financial Performance - The company's operating revenue for Q3 2024 reached ¥348,607,179.93, representing a year-on-year increase of 56.79% and a quarter-on-quarter increase of 52.70%[3]. - The net profit attributable to shareholders for Q3 2024 was ¥16,129,229.37, a decrease of 51.39% year-on-year but an increase of 115.77% quarter-on-quarter[3]. - Total operating revenue for the first three quarters of 2024 reached ¥812,429,412.28, a significant increase of 38.1% compared to ¥587,815,988.49 in the same period of 2023[15]. - The company reported a net loss of ¥52,454,293.01 for the first three quarters of 2024, contrasting with a profit of ¥79,082,621.34 in the same period of 2023[15]. - The net profit for the first three quarters of 2024 was -51,885,433.35 RMB, compared to a net profit of 79,122,653.17 RMB in the same period of 2023, representing a significant decline[16]. - The total comprehensive income for the first three quarters of 2024 was -52,209,636.55 RMB, compared to 79,193,163.78 RMB in the same period of 2023[16]. - The basic and diluted earnings per share for the first three quarters of 2024 were both -0.16 RMB, down from 0.29 RMB in the same period of 2023[16]. Research and Development - Research and development (R&D) expenses totaled ¥127,972,831.58 in Q3 2024, marking a significant increase of 167.36% year-on-year[3]. - R&D expenses accounted for 36.71% of operating revenue in Q3 2024, an increase of 15.18 percentage points compared to the same period last year[3]. - Research and development expenses surged to ¥335,115,095.66 in the first three quarters of 2024, compared to ¥144,561,274.39 in 2023, marking an increase of 132.5%[15]. Assets and Liabilities - The total assets of the company at the end of Q3 2024 were ¥3,939,097,956.50, reflecting a year-on-year increase of 14.91%[3]. - Total assets increased to ¥3,939,097,956.50 as of the end of Q3 2024, compared to ¥3,428,017,518.02 at the end of Q3 2023, representing a growth of 14.9%[14]. - Non-current liabilities totaled ¥301,827,124.75 in Q3 2024, up from ¥163,744,425.26 in Q3 2023, indicating an increase of 84.5%[14]. - The total liabilities of the company reached ¥1,566,122,800.41 in Q3 2024, compared to ¥1,017,060,959.39 in Q3 2023, an increase of 54.0%[14]. - The company's equity attributable to shareholders decreased to ¥2,372,975,156.09 in Q3 2024 from ¥2,410,956,558.63 in Q3 2023, a decline of 1.6%[14]. - Deferred income increased significantly to ¥118,629,877.87 in Q3 2024, compared to ¥52,965,192.92 in Q3 2023, representing a growth of 123.0%[14]. Cash Flow - The net cash flow from operating activities for the year-to-date period was -¥197,846,175.03, a decline of 1,276.26% year-on-year[2]. - Cash inflows from operating activities for the first three quarters of 2024 totaled 1,172,405,276.94 RMB, compared to 819,833,508.48 RMB in the same period of 2023[18]. - Cash outflows from operating activities for the first three quarters of 2024 were 1,370,251,451.97 RMB, compared to 803,013,641.04 RMB in the same period of 2023[18]. - The net cash flow from operating activities for the first three quarters of 2024 was -197,846,175.03 RMB, compared to 16,819,867.44 RMB in the same period of 2023[18]. - Cash inflows from investing activities for the first three quarters of 2024 were 2,274,937,428.42 RMB, compared to 337,612,103.51 RMB in the same period of 2023[19]. - Cash outflows from investing activities for the first three quarters of 2024 totaled 1,895,009,976.95 RMB, compared to 1,444,628,705.22 RMB in the same period of 2023[19]. - The net cash flow from investing activities for the first three quarters of 2024 was 379,927,451.47 RMB, compared to -1,107,016,601.71 RMB in the same period of 2023[19]. - The net cash flow from financing activities for the first three quarters of 2024 was -107,579,090.06 RMB, compared to 1,552,609,584.14 RMB in the same period of 2023[19]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,132[8]. - The largest shareholder, Suzhou Yiliu Mingguang Technology Co., Ltd., holds 37,800,963 shares, accounting for 11.81% of the total shares[8]. - The total number of shares held by the top ten unrestricted shareholders was 99,000,000 shares, with the largest being Guotou (Shanghai) Venture Capital Management Co., Ltd. at 36,465,943 shares[11]. - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending activities[12]. Operational Focus - The company continues to focus on high-end semiconductor quality control, with ongoing progress in new equipment validation and a growing order scale[4]. - The company is focusing on expanding its market presence and developing new technologies, although specific details were not disclosed in the report[10]. - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[12]. Stock Incentive Plan - The company has implemented a restricted stock incentive plan for 2024 to stabilize its core talent team, which has led to increased share-based payment expenses[6].

证券代码：688361 证券简称：中科飞测 公告编号：2024-042 深圳中科飞测科技股份有限公司 关于注销部分募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳中科飞测科技股份有限公司（以下简称"公司"）首次公开发行股票募 集资金按照相关法律、法规和规范性文件的规定在银行开立了募集资金专户。为 方便公司资金账户管理，减少管理成本，公司拟注销部分募集资金专户，现将具 体情况公告如下： 三、本次注销的募集资金专户情况 截至本公告披露日，公司部分募集资金专户余额较少，为方便公司资金账户 管理，减少管理成本，公司于 2024 年 10 月 30 日召开董事会审议并通过《关于 注销部分募集资金专项账户的议案》，同意注销上述募集资金专户。募集资金专 户注销前存在银行结息等少量余额的，公司将转入其他未注销的募集资金专户进 行存放及管理。募集资金专户注销后公司与该募集资金专户开户银行、保荐机构 签订的募集资金监管协议相应终止。 | | | 2 一、募集资金的基本情况 中国证券监督管理委员会于 2023 年 2 月 ...

证券代码：688361 证券简称：中科飞测 公告编号：2024-041 深圳中科飞测科技股份有限公司 第二届监事会第七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 深圳中科飞测科技股份有限公司（以下简称"公司"）第二届监事会第七次 会议于 2024 年 10 月 30 日以通讯表决方式在公司会议室召开，会议通知于 2024 年 10 月 25 日以电子邮件方式送达至全体监事。本次会议应到监事 3 人，实到监 事 3 人，会议由监事会主席陈彬女士召集并主持。会议的召集和召开程序符合 《中华人民共和国公司法》和《深圳中科飞测科技股份有限公司章程》等相关规 定，会议形成的决议合法、有效。 二、 监事会会议审议情况 （一）审议通过《关于公司<2024 年第三季度报告>的议案》 监事会认为：公司 2024 年第三季度报告的编制和审议程序符合《上海证券 交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关法律法规和规范性文件及《深圳中科飞测科技股 ...